EUVIMEDEUVIMED entdecken
Open Access

Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction

Oday Salman iD, Lei Zhao iD, Jordana B Cohen iD, Marie Joe Dib iD, Joe David Azzo iD, Sushrima Gan, A Mark Richards iD, Bianca Pourmussa iD, Rob Doughty iD, Ali Javaheri iD, Douglas L Mann iD, Ernst Rietzschel iD und 14 weitere

Journal of the American Heart Association · 03.09.2024 · 13 (17)

DOI: 10.1161/jaha.123.033660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.09.2024. Verfasst von Oday Salman und 25 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of the University of Pennsylvania Philadelphia PA USA. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Proteomics, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney disease is common in heart failure with preserved ejection fraction (HFpEF). However, the biologic correlates and prognostic significance of kidney injury (KI), in HFpEF, beyond the estimated glomerular filtration rate (eGFR), are unclear. Methods and Results Using baseline plasma samples from the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) trial, we measured the following KI biomarkers: cystatin‐C, fatty acid‐binding protein‐3, Beta‐2 microglobulin, neutrophil gelatinase‐associated lipocalin, and kidney‐injury molecule‐1. Factor analysis was used to extract the common variability underlying these biomarkers. We assessed the relationship between the KI‐factor score and the risk of death or HF‐related hospital admission in models adjusted for the Meta‐Analysis Global Group in Chronic Heart Failure risk score and eGFR. We also assessed the relationship between the KI factor score and ~5000 plasma proteins, followed by pathway analysis. We validated our findings among HFpEF participants in the Penn Heart Failure Study. KI was associated with the risk of death or HF‐related hospital admission independent of the Meta‐Analysis Global Group in Chronic Heart Failure risk score and eGFR. Both the risk score and eGFR were no longer associated with death or HF‐related hospital admission after adjusting for the KI factor score. KI was predominantly associated with proteins and biologic pathways related to complement activation, inflammation, fibrosis, and cholesterol homeostasis. KI was associated with 140 proteins, which reproduced across cohorts. Findings regarding biologic associations and the prognostic significance of KI were also reproduced in the validation cohort.

Conclusions

KI is associated with adverse outcomes in HFpEF independent of baseline eGFR. Patients with HFpEF and KI exhibit a plasma proteomic signature indicative of complement activation, inflammation, fibrosis, and impaired cholesterol homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeProteomicsBiomarkersHumansMaleFemaleAgedPrognosisMiddle AgedGlomerular Filtration RateKidney DiseasesVentricular Function, LeftMineralocorticoid Receptor AntagonistsKidneyRisk Factors

Stichwörter der Autor:innen

HFpEFcardiorenal interactionschronic kidney diseasekidney injuryoutcomesproteomics

Substanzen

BiomarkersMineralocorticoid Receptor Antagonists

Autor:innen und Institutionen

  • Hospital of the University of Pennsylvania Philadelphia PA USA.
  • Bristol Myers Squibb Company Princeton NJ USA.
  • University of Pennsylvania Perelman School of Medicine Philadelphia PA USA.
  • Cardiovascular Research Institute National University of Singapore Singapore.
  • Christchurch Heart Institute University of Otago New Zealand.
  • University of Auckland New Zealand.

ORCID-Profile: Oday Salman, Lei Zhao, Jordana B Cohen, Marie Joe Dib, Joe David Azzo, A Mark Richards, Bianca Pourmussa, Rob Doughty, Ali Javaheri, Douglas L Mann, Ernst Rietzschel, Zhaoqing Wang, Christina Ebert, Vanessa van Empel, Karl Kammerhoff, Joseph Maranville, Peter H Schafer, Dietmar Seiffert, David A Gordon, Francisco Ramirez-Valle, Thomas P Cappola, Julio A Chirinos

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Salman, O., Zhao, L., Cohen, J. B., Dib, M. J., Azzo, J. D., Gan, S., Richards, A. M., Pourmussa, B., Doughty, R., Javaheri, A., Mann, D. L., Rietzschel, E., Zhao, M., Wang, Z., Ebert, C., van Empel, V., Kammerhoff, K., Maranville, J., Gogain, J., …, & Chirinos, J. A. (2024). Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association, 13(17). https://doi.org/10.1161/jaha.123.033660

Vancouver

Salman O, Zhao L, Cohen JB, Dib MJ, Azzo JD, Gan S, et al. Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 2024;13(17). doi:10.1161/jaha.123.033660

BibTeX
@article{Salman2024,
  author = {Salman, Oday and Zhao, Lei and Cohen, Jordana B and Dib, Marie Joe and Azzo, Joe David and Gan, Sushrima and Richards, A Mark and Pourmussa, Bianca and Doughty, Rob and Javaheri, Ali and Mann, Douglas L and Rietzschel, Ernst and Zhao, Manyun and Wang, Zhaoqing and Ebert, Christina and van Empel, Vanessa and Kammerhoff, Karl and Maranville, Joseph and Gogain, Joseph and Dennis, Jaclyn and Schafer, Peter H and Seiffert, Dietmar and Gordon, David A and Ramirez-Valle, Francisco and Cappola, Thomas P and Chirinos, Julio A},
  title = {Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {17},
  doi = {10.1161/jaha.123.033660}
}
Kostenlos starten →